| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/26/2006 | CN1762463A Externally applied medicine of radix araliae armatae |
| 04/26/2006 | CN1762455A Chinese medicinal formulation for treating infant lung and stomach exuberance heat |
| 04/26/2006 | CN1762449A Medicinal wine with Damnacanthus indicus Gaertn.f. for traumatic injury |
| 04/26/2006 | CN1762446A Medicinal wine of Asarum maximum Hemsl. for traumatic injury |
| 04/26/2006 | CN1762445A Medicinal wine for traumatic injury and its preparation method |
| 04/26/2006 | CN1762444A Externally medicine of Aconitun sungpanense Hand -Mazz |
| 04/26/2006 | CN1762443A Rubia root medicinal wine for injury |
| 04/26/2006 | CN1762437A Bolus for treating rheumatic or rheumatoid arthritis and its preparation method |
| 04/26/2006 | CN1762436A Externally applied medicine of Ligularia lapathifolia |
| 04/26/2006 | CN1762435A Red peony root medicinal wine for injury |
| 04/26/2006 | CN1762432A Medicinal wine with piper boehmeriaefolium wall for traumatic injury |
| 04/26/2006 | CN1762431A Giant knotweed pills formula and its preparation method |
| 04/26/2006 | CN1762429A Forsythia fruit pills formula and its preparation method |
| 04/26/2006 | CN1762426A Externally applied medicine of Japanese thistle |
| 04/26/2006 | CN1762422A Process for preparing soft capsule of red sage root and notoginseng |
| 04/26/2006 | CN1762419A Lamiophlomis rotata Kudo pills formula and its preparation method |
| 04/26/2006 | CN1762418A Celasfl medicinal wine for traumatic injury |
| 04/26/2006 | CN1762414A Externally applied medicine of clematis armandi franch |
| 04/26/2006 | CN1762413A Desmodium caudatum herbal wine for traumatic injury |
| 04/26/2006 | CN1762412A Winterberry euonymus herbal wine for traumatic injury |
| 04/26/2006 | CN1762411A Dendropanax chevalieri herbal wine for traumatic injury |
| 04/26/2006 | CN1762403A Soft capsule of erigeron breviscapus effective component extracts and preparation method thereof |
| 04/26/2006 | CN1762402A Dispersible tablet of erigeron breviscapus effective component extracts and preparation method thereof |
| 04/26/2006 | CN1762398A Method for extracting ferula feruloides medicinal composition |
| 04/26/2006 | CN1762394A Trogopterus dung-containing pain-relieving pill formula and its preparation method |
| 04/26/2006 | CN1762384A Bear gall pill formula and its preparation method |
| 04/26/2006 | CN1762363A Arteannuin pills formula and its preparation process |
| 04/26/2006 | CN1762359A Lindera root alkaloid, its preparation method and application in medicine preparation |
| 04/26/2006 | CN1762349A Externally applied ointment of ketorolac tromethamine and its preparation method |
| 04/26/2006 | CN1253470C Treatment of inflammatory disease |
| 04/26/2006 | CN1253452C Thioether subsituted imidazoquinoline compound |
| 04/26/2006 | CN1253449C Indolylmaleimide derivatives as protein kinase C inibitors |
| 04/26/2006 | CN1253441C Protease inhibitors |
| 04/26/2006 | CN1253435C Aryl oxime-piperazines useful as CCR5 antagonists |
| 04/26/2006 | CN1253197C Medicine for treating rheumatoid and rheumatic arthritis and preparation method thereof |
| 04/26/2006 | CN1253192C Medicine for treating summer heat wetness cold and preparing method |
| 04/26/2006 | CN1253191C Chinese traditional medicine for treating acute and chronic appendicitis |
| 04/26/2006 | CN1253180C Externally applied Chinese medicinal plaster for treating bone pain |
| 04/26/2006 | CN1253160C Medicine for treating fiver by nasal application and its preparing process |
| 04/26/2006 | CN1253149C Percutaneously absorbable patches |
| 04/25/2006 | US7034692 System and method for transparent early detection, warning, and intervention during a medical procedure |
| 04/25/2006 | US7034176 Aminopropylphosphinic acids |
| 04/25/2006 | US7034153 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease |
| 04/25/2006 | US7034151 1,4-dihydro-4-oxo-pyrrolo[2,1-f][1,2,4]triazine-6-carboxylates; novel approach to the formation of the bicyclic heterocyclic ring system |
| 04/25/2006 | US7034131 Antibody therapy; immobilization |
| 04/25/2006 | US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease |
| 04/25/2006 | US7034043 Cell adhesion inhibitors |
| 04/25/2006 | US7034042 Corticotropin releasing factor receptor antagonist |
| 04/25/2006 | US7034033 Substituted quinazolinone compounds |
| 04/25/2006 | US7034031 Modulators of TNF-α signaling |
| 04/25/2006 | US7034028 Treatment of inflammatory disorders |
| 04/25/2006 | US7034027 Method of treating a male or female animal in the treatment of a condition where inhibition of a cGMP-specific PDE is of a therapeutic benefit comprising treating said animal with an effective amount of a pharmaceutical composition with carriers |
| 04/25/2006 | US7034022 Proteases, kinases enzyme inhibitors; cardiovascular disorders; central nervous system disorders; antiinflammatrory agents; bone disorders; infections |
| 04/25/2006 | US7034018 Substituted pyrrole mannich bases to combat pain and allergic reactions |
| 04/25/2006 | US7033807 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 04/25/2006 | US7033604 Composition for topical administration |
| 04/25/2006 | US7033575 Delivery of physiologically active compounds through an inhalation route |
| 04/25/2006 | CA2438097C Cannabinoids pharmaceutical formulations |
| 04/25/2006 | CA2194885C Substituted benzamidines, their preparation and their use as pharmaceutical compounds |
| 04/20/2006 | WO2006041961A1 Arylthioindole tubulin polymerization inhibitors and methods of treating or preventing cancer using same |
| 04/20/2006 | WO2006041888A2 Substituted aryl or heteroarylsulfonylbutanamides for use as anti-inflammatory agents |
| 04/20/2006 | WO2006041197A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ |
| 04/20/2006 | WO2006041121A1 Remedies/preventives for chronic skin disease |
| 04/20/2006 | WO2006041019A1 Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride or hydrate thereof and intermediate for the same |
| 04/20/2006 | WO2006041015A1 Amino alcohol derivative, addition salt thereof and immunosuppressive agent |
| 04/20/2006 | WO2006040980A1 Lecithinized superoxide dismutase composition and process for producing the same |
| 04/20/2006 | WO2006040676A1 Nitrosated benzopyran compounds as novel cyclooxygenase-2 selective inhibitors |
| 04/20/2006 | WO2006040672A1 Substituted cyclopropyl chromene compounds for use in the treatment and prevention of inflammation related conditions |
| 04/20/2006 | WO2006040666A1 Substituted n-alkylpyrimidinones |
| 04/20/2006 | WO2006040004A1 Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 04/20/2006 | WO2006018609A3 Anti-inflammatory agents |
| 04/20/2006 | WO2005123115A8 Methods of modulating cellular activity involving sphingosine kinase and agents for same, and sphingosine kinase variants |
| 04/20/2006 | US20060084809 Compounds as PDE IV and TNF-inhibitors |
| 04/20/2006 | US20060084703 Injectable liquid formulation of paracetamol |
| 04/20/2006 | US20060084699 Antagonists of the B2 receptor of bradykinin; analgesics; hyperalgesia and major algesia; cancer; nontoxic; industrial scale; 5-[[(2,4-dichloro-3-methylphenyl)sulphonyl]methylamino]-N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-N-methyl-pentanamide |
| 04/20/2006 | US20060084688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 04/20/2006 | US20060084685 Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 04/20/2006 | US20060084684 Topically applicable pharmaceutical preparation |
| 04/20/2006 | US20060084677 2-sulfo, sulfanyl, sulfinyl, sulfonyl, or sulfamyl-5-substituted-6-sulfonyl quinolines; sulfiding, oxidation, dehalogenation or aralkylation of the 6-sulfonylquinoline; selective cyclooxygenase-2 inhibitors, analgesics; side effect reduction |
| 04/20/2006 | US20060084667 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 04/20/2006 | US20060084664 Substituted pyrido(1,2-A) pyrimidines and their use as NOS inhibitors |
| 04/20/2006 | US20060084653 Beta-sheet mimetics and composition and methods relating thereto |
| 04/20/2006 | US20060084641 IL-8 receptor antagonists |
| 04/20/2006 | US20060084614 Anticoagulants; bioavailability, lower toxicity; 1-(glycosyl substituted phenylmethylamino)-4-amidino-benzene derivatives |
| 04/20/2006 | US20060084613 Dipeptide enzyme inhibitor; antiinflammatory agents; autoimmune disease; wound healing agents |
| 04/20/2006 | US20060084121 OX2 receptor homologs |
| 04/20/2006 | US20060083792 Utilizing nanocrystalline silver metal, alloy or compound for localized tissue infections; reducing side effects; limiting overuse of antibiotics |
| 04/20/2006 | US20060083790 Combination of an ibat inhibitor and a metal salt for the treatment of diarrhoea |
| 04/20/2006 | US20060083784 Amorphous pharmaceutical compositions |
| 04/20/2006 | US20060083740 By modulating the expression of mutant and wild type CD83 gene products produced in a mammal; regulation of T cell and dendritic cell activity; antibodies |
| 04/20/2006 | US20060083692 Combination of formoterol and a tiotropium salt |
| 04/20/2006 | CA2584169A1 Remedies/preventives for chronic skin disease |
| 04/20/2006 | CA2583920A1 Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 04/20/2006 | CA2583846A1 Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride or hydrates thereof, and intermediates in the production thereof |
| 04/20/2006 | CA2582933A1 4-phenylsulfonamidopiperidines as calcium channel blockers |
| 04/20/2006 | CA2582459A1 Substituted sulfones and methods of use |
| 04/20/2006 | CA2580497A1 Substituted n-alkylpyrimidinones |
| 04/20/2006 | CA2580271A1 Method for treating vasculitis |
| 04/19/2006 | EP1647597A1 Chemokine N-terminal deletion mutations |
| 04/19/2006 | EP1646627A1 Chemical compounds containing tocopherol and at least one additional pharmaceutical active substance |